Although more elaborate studies are needed, LPA–LPAR1 axis might be a good target to develop therapeutic strategies to improve the prognosis of advanced osteosarcomas by preventing metastasis from the beginning of therapy using anticancer agents. The gene discussed is LPAR1; the disease is osteosarcoma.